Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 7 de 7
1.
Pestic Biochem Physiol ; 200: 105806, 2024 Mar.
Article En | MEDLINE | ID: mdl-38582572

Boscalid, a widely used SDHI fungicide, has been employed in plant disease control for over two decades. However, there is currently no available information regarding its antifungal activity against Sclerotium rolfsii and the potential risk of resistance development in this pathogen. In this study, we evaluated the sensitivity of 100 S. rolfsii strains collected from five different regions in China during 2018-2019 to boscalid using mycelial growth inhibition method and assessed the risk of resistance development. The EC50 values for boscalid ranged from 0.2994 µg/mL to 1.0766 µg/mL against the tested strains, with an average EC50 value of 0.7052 ± 0.1473 µg/mL. Notably, a single peak sensitivity baseline was curved, indicating the absence of any detected resistant strains. Furtherly, 10 randomly selected strains of S. rolfsii were subjected to chemical taming to evaluate its resistance risk to boscalid, resulting in the successful generation of six stable and inheritable resistant mutants. These mutants exhibited significantly reduced mycelial growth, sclerotia production, and virulence compared to their respective parental strains. Cross-resistance tests revealed a correlation between boscalid and flutolanil, benzovindiflupyr, pydiflumetofen, fluindapyr, and thifluzamide; however, no cross-resistance was observed between boscalid and azoxystrobin. Thus, we conclude that the development risk of resistance in S. rolfsii to boscalid is low. Boscalid can be used as an alternative fungicide for controlling peanut sclerotium blight when combined with other fungicides that have different mechanisms of action. Finally, the target genes SDHB, SDHC, and SDHD in S. rolfsii were initially identified, cloned and sequenced to elucidate the mechanism of S. rolfsii resistance to boscalid. Two mutation genotypes were found in the mutants: SDHD-D111H and SDHD-H121Y. The mutants carrying SDHD-H121Y exhibited moderate resistance, while the mutants with SDHD-D111H showed low resistance. These findings contribute to our comprehensive understanding of molecular mechanisms underlying plant pathogens resistance to SDHI fungicides.


Basidiomycota , Biphenyl Compounds , Fungicides, Industrial , Niacinamide/analogs & derivatives , Fungicides, Industrial/pharmacology , Succinate Dehydrogenase , Risk Assessment , Plant Diseases/microbiology
2.
Clin Imaging ; 35(5): 329-35, 2011.
Article En | MEDLINE | ID: mdl-21872120

OBJECTIVE: Our aim was to investigate the statistical preoperative diagnostic criteria of lesions of Meckel's cave (MC) on MRI. MATERIALS AND METHODS: We retrospectively reviewed the MR images with MC lesions in 34 patients. The MR signs were compared with histopathologic and surgical findings in all lesions. Odds ratio values and the confidence intervals of the MRI diagnostic criteria were evaluated by univariate logistic regression. RESULTS: The following three signs of MC on post-contrast T1WI of MRI have been found to represent the most valuable criterion for determination of MC lesion: (1) contrast enhancement, (2) bulging of lateral wall, and (3) the absence of normal MC, with odds ratios of 362.67 (P<.001), 40.38 (P = .001), and 40.38 (P = .001) individually. CONCLUSION: Contrast enhancement on post-contrast T1WI is the most sensitive MR sign for demonstrating the presence of MC lesion.


Brain Diseases/diagnosis , Cavernous Sinus/pathology , Magnetic Resonance Imaging/methods , Adolescent , Adult , Aged , Aged, 80 and over , Brain Diseases/pathology , Chi-Square Distribution , Contrast Media , Female , Humans , Logistic Models , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies , Sensitivity and Specificity
3.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi ; 28(6): 1145-7, 1153, 2011 Dec.
Article Zh | MEDLINE | ID: mdl-22295703

This study was to investigate the relationship of dose-effect and time-effect of Alginate-Polylysine-Alginate (APA) microencapsulated bovine chromaffin cells on the treatment of pain model rats. Using a rat model of painful peripheral neuropathy, the antinociceptive effects of APA microencapsulated bovine cells transplanted into the subarachnoid space was evaluated by cold allodynia test and hot hyperalgesia test. Compared with control group, the withdrawal difference with cell number 50 thousands groups, 100 thousands groups and 200 thousands groups was reduced (P < 0.05), and the difference decreased with the cells increases, indicating a significant analgesic effect. There was no significant difference between 400 thousands groups and 200 thousands groups. This analgesic effect maintained longer than 12 weeks. There was a positive correlation between the analgesic effect and the quantity of APA microencapsulated bovine chromaffin cells which were transplanted to treat pain model rats, and the effective antinociception remained longer than 12 weeks.


Alginates/administration & dosage , Analgesia/methods , Chromaffin Cells/transplantation , Implants, Experimental , Pain Management/methods , Polylysine/analogs & derivatives , Alginates/pharmacology , Animals , Cattle , Dose-Response Relationship, Drug , Drug Compounding , Polylysine/administration & dosage , Polylysine/pharmacology , Rats , Sciatica/therapy
4.
Zhongguo Dang Dai Er Ke Za Zhi ; 10(4): 467-70, 2008 Aug.
Article Zh | MEDLINE | ID: mdl-18706163

OBJECTIVE: To investigate the diet and nutritional status of hospitalized children with blood disease in order to provide nutritional guidelines. METHODS: The patients' daily dietary intakes, including breakfast, lunch, dinner and additional meals, were recorded in detail for seven consecutive days. The intake amount of various nutrients was calculated using the dietary database. RESULTS: The majority of children with blood disease showed inadequate intakes of calories [mean 1825.81 kCal/d, 73.62% of the recommended intake (RNI)] and protein (mean 67.68 g/d, 81.34% of RNI). Intakes of vitamin E and riboflavin were adequate, but intakes of vitamin A, thiamine and vitamin C (66.67%, 77.78% and 69.89% of RNI, respectively) were inadequate. Iron and selenium intakes were adequate, but calcium and zinc intakes (41.11% and 56.21% of RNI, respectively) were grossly inadequate. CONCLUSIONS: Hospitalized children with blood disease had decreased dietary intakes of calories, protein, vitamin A, vitamin C, thiamin, calcium and zinc. The dietary pattern and nutritional intake need to be improved.


Energy Intake , Hematologic Diseases/metabolism , Nutritional Status , Adolescent , Ascorbic Acid/administration & dosage , Child , Child, Preschool , Female , Hospitalization , Humans , Infant , Male , Reactive Oxygen Species/metabolism , Selenium/administration & dosage , Vitamin A/administration & dosage , Zinc/administration & dosage
5.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi ; 23(1): 166-9, 2006 Feb.
Article Zh | MEDLINE | ID: mdl-16532833

This article presents the design of a bioreactor using hollow fiber membrane and, isolated hepatocytes of suckling pigs, and the experimental study of its efficacy in vitro. Liver cells were harvested from suckling pigs with collagenase perfusion in situ, and parenchymal and non-parenchymal hepatocytes were cocultured in a hollow fiber module which was rotated sporadically. Bioartificial liver(BAL) was developed using this bioreactor,and the BAL was perfused with ascites of patients suffering from liver cirrhosis. The yield of viable hepatocytes was (6.29 +/- 0.37) x 10(8) cells, and cell viability was greater than 84%. Hepatocytes aggregated to multi-cells spheroids after being rotated every thirty minutes for three hours. The hepatocytes in the bioreactor could synthesize urea. Total billirubin was decreased, and AST was significantly increased in the group of bioreactor, as compared with that in the control group. Glucose decreased in the group of bioreactor,whereas there was no significant descent in the control group; and the difference between the two groups was significant. The above results demonstrate that this bioreactor is effective for decreasing total bilirubin and glucose.


Bioreactors , Hepatocytes/cytology , Liver, Artificial , Animals , Animals, Newborn , Cell Separation , Cells, Cultured , Swine
6.
J Laryngol Otol ; 118(2): 106-11, 2004 Feb.
Article En | MEDLINE | ID: mdl-14979946

The quantitative relationships between the position of the mastoid segment of the facial nerve, mastoid pneumatization and the positions of neighbouring structures are undetermined. Using high resolution computed tomography (HRCT), the positions of these structures were measured in 66 normal temporal bones. A new method for measuring the volume of pneumatization in the temporal bone based on the serial digital images of CT was designed. The method of partial correlation analysis was used to find the real relationship of the two variables. The results suggest that the factors that influence the position of the mastoid segment of the facial nerve are complicated and multiple. The development of the cranium including the temporal bone, the temporal bone pneumatization and the variable position of the jugular bulb are considered to be important factors.


Facial Nerve/anatomy & histology , Temporal Bone/anatomy & histology , Adult , Aged , Craniotomy , Facial Nerve/diagnostic imaging , Female , Gender Identity , Humans , Image Processing, Computer-Assisted , Jugular Veins/anatomy & histology , Jugular Veins/diagnostic imaging , Male , Middle Aged , Reference Values , Temporal Bone/diagnostic imaging , Tomography, X-Ray Computed
7.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi ; 20(1): 135-8, 2003 Mar.
Article Zh | MEDLINE | ID: mdl-12744184

This paper reviews the development of the polyanhydrides as a new biodegradable polymer, and highlights the methodological and technological progress in the synthesis of the polymer. Subsequently, the future researches and developments of polyanhydrides are prospected.


Anhydrides , Biocompatible Materials , Drug Delivery Systems , Polymers , Anhydrides/chemical synthesis , Animals , Biocompatible Materials/chemical synthesis , Brain Neoplasms/drug therapy , Delayed-Action Preparations , Diabetes Mellitus/drug therapy , Drug Carriers , Glioma/drug therapy , Humans , Osteomyelitis/drug therapy , Polymers/chemical synthesis , Rats
...